About ViroBiome™ & Us

ViroBiome™ develops patented plant-derived bioactive technologies designed to reinforce biological interfaces and support next-generation Augmented Hygiene systems.

Our work is based on a simple conviction: effective protection begins at the biological interface.

A Platform Approach

ViroBiome™ was built at the intersection of:

• plant bioactive science
• microbiome-compatible design
• biological interface support
• barrier reinforcement research
• controlled-release architectures

Our technologies are structured as a modular platform designed for scalable integration into hygiene, personal care, respiratory comfort, functional nonwovens and selected medical-adjacent applications.

Augmented Hygiene

Traditional hygiene models focus primarily on elimination.

ViroBiome™ advances a complementary paradigm: Augmented Hygiene.

This approach emphasizes:

• reinforcement rather than disruption
• modulation rather than eradication
• preservation of commensal microbiomes
• support of natural barrier functions
• compatibility with existing industrial processes

It aligns with the One Health perspective, connecting human, animal and environmental resilience.

Industrial Orientation

Our patented technologies are engineered for scalable integration into:

• personal and intimate hygiene systems
• respiratory comfort applications
• barrier-oriented dermal products
• functional nonwoven substrates
• consumer tissue products
• selected medical-adjacent supports

The objective is to enable next-generation interface-support systems without requiring major structural changes to existing manufacturing infrastructures.

Scientific Foundation

ViroBiome™ is supported by multidisciplinary research in:

• plant-derived bioactives
• lipid-based barrier support
• microbiome-compatible formulation science
• controlled-release interface systems
• biological barrier reinforcement

Research documentation, formulation data and intellectual property files are available under confidentiality agreement with qualified industrial partners.

Strategic Vision

We envision protection evolving from elimination-based chemistry toward biologically active interface systems.

From elimination to modulation.
From disruption to resilience.
From isolated protection to integrated health.

Organizational Approach

ViroBiome™ operates through a multidisciplinary model combining:

• bioactive research
• formulation development
• industrial strategy
• regulatory-aware positioning
• cross-sector innovation

We position ourselves at the interface of biotechnology, preventive hygiene and sustainable systems integration.

Our Team

ViroBiome™ is driven by a multidisciplinary team combining scientific research expertise, formulation and bioactive development, industrial strategy and cross-sector innovation.

We operate at the intersection of biotechnology, preventive hygiene and sustainable innovation, with the ambition to build biologically smarter hygiene and interface-protection systems.

ViroBiome™ develops patented biological interface technologies designed to reinforce, protect and modulate human and environmental interfaces.

Our innovation strategy is based on combining plant-derived bioactives, barrier-supporting materials and proprietary multi-compartment architectures to create next-generation solutions for hygiene, healthcare and functional materials.

The platform is designed for integration into existing industrial manufacturing processes and can be adapted to multiple product categories, including functional nonwovens, oral care, respiratory care, personal hygiene, medical disposables and consumer health products.

ViroBiome™ follows a collaborative innovation model focused on co-development, industrial validation and licensing partnerships. Our objective is to help industry transition from passive materials toward functional biological interfaces that support comfort, resilience and surface protection through non-biocidal approaches.

The platform is supported by proprietary know-how, patent-protected technologies and validation data generated through laboratory, ex vivo and human compatibility studies.